Cathelicidin LL-37 in Health and Diseases of the Oral Cavity

被引:27
|
作者
Tokajuk, Joanna [1 ,2 ]
Deptula, Piotr [1 ]
Piktel, Ewelina [3 ]
Daniluk, Tamara [1 ]
Chmielewska, Sylwia [1 ]
Wollny, Tomasz [4 ]
Wolak, Przemyslaw [5 ]
Fiedoruk, Krzysztof [1 ]
Bucki, Robert [1 ]
机构
[1] Med Univ Bialystok, Dept Med Microbiol & Nanobiomed Engn, Mickiewicza 2C, PL-15222 Bialystok, Poland
[2] Dent & Med Tokajuk, Zelazna 9-7, PL-15297 Bialystok, Poland
[3] Med Univ Bialystok, Independent Lab Nanomed, Mickiewicza 2B, PL-15222 Bialystok, Poland
[4] Holy Cross Oncol Ctr Kielce, Artwinskiego 3, PL-25734 Kielce, Poland
[5] Jan Kochanowski Univ Kielce, Coll Med, Inst Med Sci, IX Wiekow Kielc 19A, PL-25317 Kielce, Poland
关键词
oarl cavity; human cathelicidin; antimicrobial peptides; immunomodulation; ANTIMICROBIAL PEPTIDE LL-37; GINGIVAL CREVICULAR FLUID; PORPHYROMONAS-GINGIVALIS; ANTIBACTERIAL ACTIVITY; GROWTH-FACTOR; SALIVARY CONCENTRATION; EPITHELIAL-CELLS; INNATE IMMUNITY; MYELOID CELLS; CANCER-CELLS;
D O I
10.3390/biomedicines10051086
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The mechanisms for maintaining oral cavity homeostasis are subject to the constant influence of many environmental factors, including various chemicals and microorganisms. Most of them act directly on the oral mucosa, which is the mechanical and immune barrier of the oral cavity, and such interaction might lead to the development of various oral pathologies and systemic diseases. Two important players in maintaining oral health or developing oral pathology are the oral microbiota and various immune molecules that are involved in controlling its quantitative and qualitative composition. The LL-37 peptide is an important molecule that upon release from human cathelicidin (hCAP-18) can directly perform antimicrobial action after insertion into surface structures of microorganisms and immunomodulatory function as an agonist of different cell membrane receptors. Oral LL-37 expression is an important factor in oral homeostasis that maintains the physiological microbiota but is also involved in the development of oral dysbiosis, infectious diseases (including viral, bacterial, and fungal infections), autoimmune diseases, and oral carcinomas. This peptide has also been proposed as a marker of inflammation severity and treatment outcome.
引用
收藏
页数:30
相关论文
共 50 条
  • [1] Cathelicidin LL-37: A Multitask Antimicrobial Peptide
    Bucki, Robert
    Leszczynska, Katarzyna
    Namiot, Andrzej
    Sokolowski, Wojciech
    ARCHIVUM IMMUNOLOGIAE ET THERAPIAE EXPERIMENTALIS, 2010, 58 (01) : 15 - 25
  • [2] Cathelicidin LL-37 in periodontitis: current research advances and future prospects- A review
    He, Yeqing
    Zhou, Yuxi
    Liu, Na
    Zhang, Weijun
    Chen, Xiaomin
    Qiu, Guopeng
    Shen, Yuqin
    INTERNATIONAL IMMUNOPHARMACOLOGY, 2025, 150
  • [3] Circulating cathelicidin LL-37 in adult patients with pulmonary infectious diseases
    Majewski, Karol
    Zelechowska, Paulina
    Brzezinska-Blaszczyk, Ewa
    CLINICAL AND INVESTIGATIVE MEDICINE, 2017, 40 (01): : E34 - E39
  • [4] SERUM LEVEL OF CATHELICIDIN LL-37 IN PATIENTS WITH ACTIVE TUBERCULOSIS AND OTHER INFECTIOUS DISEASES
    Majewski, K.
    Agier, J.
    Kozlowska, E.
    Brzezinska-Blaszczyk, E.
    JOURNAL OF BIOLOGICAL REGULATORS AND HOMEOSTATIC AGENTS, 2017, 31 (03): : 731 - 736
  • [5] Unique features of human cathelicidin LL-37
    Bandurska, Katarzyna
    Berdowska, Agnieszka
    Barczynska-Felusiak, Renata
    Krupa, Piotr
    BIOFACTORS, 2015, 41 (05) : 289 - 300
  • [6] The Role of Cathelicidin LL-37 in Cancer Development
    Piktel, Ewelina
    Niemirowicz, Katarzyna
    Wnorowska, Urszula
    Watek, Marzena
    Wollny, Tomasz
    Gluszek, Katarzyna
    Gozdz, Stanislaw
    Levental, Ilya
    Bucki, Robert
    ARCHIVUM IMMUNOLOGIAE ET THERAPIAE EXPERIMENTALIS, 2016, 64 (01) : 33 - 46
  • [7] A comprehensive summary of LL-37, the factotum human cathelicidin peptide
    Vandamme, Dieter
    Landuyt, Bart
    Luyten, Walter
    Schoofs, Liliane
    CELLULAR IMMUNOLOGY, 2012, 280 (01) : 22 - 35
  • [8] Heterogeneous expression of human cathelicidin hCAP18/LL-37 in inflammatory bowel diseases
    Schauber, Juergen
    Rieger, Daniel
    Weiler, Frank
    Wehkamp, Jan
    Eck, Matthias
    Fellermann, Klaus
    Scheppach, Wolfgang
    Gallo, Richard L.
    Stange, Eduard F.
    EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY, 2006, 18 (06) : 615 - 621
  • [9] Low serum levels of cathelicidin LL-37 in leprosy
    Matzner, Michael
    Al Samie, Abdul Rahim
    Winkler, Heide-Maria
    Nemeth, Johannes
    Grasnek, Andreas
    Indra, Alexander
    Bieglmayer, Christian
    Winkler, Stefan
    ACTA TROPICA, 2011, 117 (01) : 56 - 59
  • [10] The Roles of Cathelicidin LL-37 in Inflammatory Bowel Disease
    Sun, Lihua
    Wang, Wensheng
    Xiao, Weidong
    Yang, Hua
    INFLAMMATORY BOWEL DISEASES, 2016, 22 (08) : 1986 - 1991